Limitations of presently available glycopeptides in the treatment of Gram-positive infection.
about
In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis.Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?Industrial natural product chemistry for drug discovery and development.Occurrence, structure, and mobility of Tn1546-like elements in environmental isolates of vancomycin-resistant enterococci.
P2860
Limitations of presently available glycopeptides in the treatment of Gram-positive infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Limitations of presently avail ...... nt of Gram-positive infection.
@ast
Limitations of presently avail ...... nt of Gram-positive infection.
@en
Limitations of presently avail ...... nt of Gram-positive infection.
@nl
type
label
Limitations of presently avail ...... nt of Gram-positive infection.
@ast
Limitations of presently avail ...... nt of Gram-positive infection.
@en
Limitations of presently avail ...... nt of Gram-positive infection.
@nl
prefLabel
Limitations of presently avail ...... nt of Gram-positive infection.
@ast
Limitations of presently avail ...... nt of Gram-positive infection.
@en
Limitations of presently avail ...... nt of Gram-positive infection.
@nl
P1476
Limitations of presently avail ...... nt of Gram-positive infection.
@en
P2093
P356
10.1046/J.1469-0691.2001.00059.X
P478
P577
2001-01-01T00:00:00Z